September 30, 2024
Late last week, a US Food and Drug Administration (FDA) panel met to discuss whether to limit the use of nivolumab (Opdivo) and pembrolizumab (Keytruda) in […]
September 30, 2024
AMSTERDAM — For patients with atopic dermatitis (AD) who responded to the anti-interleukin (IL)-13 monoclonal antibody lebrikizumab in the pivotal trials, the level of response, including […]
September 30, 2024
Nonprofit hospitals in the United States received tax breaks worth $37.4 billion in 2021, subsidized partly by property taxes in surrounding communities, a new JAMA study […]
September 30, 2024
In 2012, Tara Rynders’ sister was diagnosed with acute disseminated encephalomyelitis. For Rynders, a registered nurse in Denver, Colorado, the news was devastating. “She was this […]
September 30, 2024
TOPLINE: Compared with placebo, a 72-hour infusion of 1 ng/kg/min iloprost does not improve outcomes or reduce the severity of organ failure among patients admitted to […]
September 30, 2024
SAN DIEGO — Although it has been known for several years that more than 1000 species of bacteria from 19 different phyla inhabit the human skin […]
September 30, 2024
Mexico is among the countries with the highest firearm mortality rates. Although these rates decreased slightly between 2018 and 2022, firearm mortality remains a major public […]
September 30, 2024
TOPLINE: A fresh frozen plasma (FFP) to red blood cell (RBC) transfusion ratio above 1 is associated with decreased in-hospital mortality in patients with severe blunt […]
September 30, 2024
RIO DE JANEIRO — The addition of daratumumab to lenalidomide maintenance therapy following autologous stem cell transplant (ASCT) significantly improves rates of achieving minimal residual disease […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434
Next page